SCHEMBL29959345

SCHEMBL29959345

CCN1CCC[C@H]1CNC(=O)c1cc(Br)cc(OC)c1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
DRD3 P35462 4/20 0.81
DRD2 P14416 5/20 0.76
DRD4 P21917 2/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10355469 0.89 DRD3 (1.00) DRD3DRD2DRD4
SCHEMBL5477770 0.89 DRD3 (1.00) DRD3DRD2DRD4
SCHEMBL10355542 0.89 DRD3 (1.00) DRD3DRD2DRD4
SCHEMBL11046144 0.86 DRD2 (1.00) DRD3DRD2DRD4
SCHEMBL10355444 0.85 DRD2 (1.00) DRD3DRD2
SCHEMBL10355445 0.85 DRD2 (1.00) DRD3DRD2
SCHEMBL9550057 0.82 DRD2 (0.85) DRD3DRD2DRD4
SCHEMBL9550045 0.82 DRD2 (0.85) DRD3DRD2DRD4
SCHEMBL9550006 0.81 DRD3 (1.00) DRD3DRD2DRD4
SCHEMBL9549986 0.81 DRD3 (1.00) DRD3DRD2DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118397472-A Diversified feature learning SAR ship detection method based on neural equation guidance 西安电子科技大学 2024-07-26 CN claimed
CN-122012362-A Method for producing L-valine, genetically engineered bacterium and application thereof 天津科技大学 2026-05-12 CN disclosed
US-12548500-B2 Display device having power connection lines between first and second data connection line groups and electronic device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2026-02-10 US disclosed
US-20250225922-A1 DISPLAY DEVICE AND ELECTRONIC DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2025-07-10 US disclosed
US-12324860-B2 Methods of treating central nervous system disorders via administration of nanoparticles of an mTOR inhibitor and an albumin ABRAXIS BIOSCIENCE, LLC (US) 2025-06-10 US disclosed
US-20240299313-A1 METHODS OF TREATING CENTRAL NERVOUS SYSTEM DISORDERS VIA ADMINISTRATION OF NANOPARTICLES OF AN MTOR INHIBITOR AND AN ALBUMIN ABRAXIS BIOSCIENCE, LLC 2024-09-12 US disclosed
CN-118397472-A Diversified feature learning SAR ship detection method based on neural equation guidance 西安电子科技大学 2024-07-26 CN disclosed
CN-118397472-A Diversified feature learning SAR ship detection method based on neural equation guidance 西安电子科技大学 2024-07-26 CN disclosed
US-11944708-B2 Methods of treating central nervous system disorders via administration of nanoparticles of an mTOR inhibitor and an albumin ABRAXIS BIOSCIENCE, LLC (US) 2024-04-02 US disclosed
US-20240075084-A1 KLEBSIELLA BACTERIOPHAGE AND USES THEREOF BIOMX LTD. (IL) 2024-03-07 US disclosed
EP-4281094-A1 KLEBSIELLA BACTERIOPHAGE AND USES THEREOF Biomx Ltd. (IL) 2023-11-29 EP disclosed
US-20230149295-A1 INFLAMMATORY BOWEL DISEASE STEM CELLS, AGENTS WHICH TARGET IBD STEM CELLS, AND USES RELATED THERETO UNIVERSITY OF HOUSTON SYSTEM (US) 2023-05-18 US disclosed
EP-4121111-A1 METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY AND FIBROTIC PULMONARY DISORDERS University of Houston System (US) 2023-01-25 EP disclosed
EP-4117718-A1 INFLAMMATORY BOWEL DISEASE STEM CELLS, AGENTS WHICH TARGET IBD STEM CELLS, AND USES RELATED THERETO University of Houston System (US) 2023-01-18 EP disclosed
US-11550738-B2 Storage device including reconfigurable logic and method of operating the storage device SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-01-10 US disclosed
WO-2022157776-A1 KLEBSIELLA BACTERIOPHAGE AND USES THEREOF BIOMX LTD. (IL) 2022-07-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12548500-B2 Display device having power connection lines between first and second data connection line groups and electronic device including the same EPHA8, EPHA4, EPHA7 DRD3 1149/4885DRD2 648/4885DRD4 1199/4885
US-20230149295-A1 INFLAMMATORY BOWEL DISEASE STEM CELLS, AGENTS WHICH TARGET IBD STEM CELLS, AND USES RELATED THERETO EPCAM, FABP2, TPMT DRD3 3676/4885DRD2 4079/4885DRD4 4028/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.